高尿酸血症(Hyperuricemia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016305)
◆英語タイトル:Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016305
◆発行日:2019年01月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥654,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[高尿酸血症(Hyperuricemia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、高尿酸血症(Hyperuricemia)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・高尿酸血症(Hyperuricemia):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・高尿酸血症(Hyperuricemia)のフェーズ3治験薬の状況
・高尿酸血症(Hyperuricemia)治療薬の市場規模(販売予測)
・高尿酸血症(Hyperuricemia)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・高尿酸血症(Hyperuricemia)のフェーズ3治験薬分析
・開発中止中の高尿酸血症(Hyperuricemia)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hyperuricemia Report is to understand the market and pipeline status of the drugs around the Hyperuricemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hyperuricemia. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Hyperuricemia.
• A review of the marketed products under prescription for Hyperuricemia, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Hyperuricemia with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Hyperuricemia drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Hyperuricemia drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Hyperuricemia drugs.
• Coverage of Hyperuricemia Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for Hyperuricemia
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Hyperuricemia
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Hyperuricemia
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• Hyperuricemia Therapeutic Market, US, (Year), 2018
• Hyperuricemia Marketed Drugs, API Manufacturers by US DMF Status, 2018
• Hyperuricemia Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Drugs, API Manufacturers, Europe by Country, 2018
• Hyperuricemia Drugs, API Manufacturers, India by State, 2018
• Hyperuricemia Drugs, API Manufacturers, China by Province, 2018
• Hyperuricemia Drugs, API Manufacturers by Geography 2018
• Hyperuricemia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for Hyperuricemia, 2018
• Discontinued Drugs for Hyperuricemia, 2018


List of Figures
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• Hyperuricemia Therapeutic Market, US, (Year), 2018
• Hyperuricemia Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• Hyperuricemia Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Drugs, API Manufacturers, Europe by Country, 2018
• Hyperuricemia Drugs, API Manufacturers, India by State, 2018
• Hyperuricemia Drugs, API Manufacturers, China by Province, 2018
• Hyperuricemia Drugs, API Manufacturers by Geography 2018
• Hyperuricemia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

高尿酸血症(Hyperuricemia)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • シロップ及びスプレッド市場の展望(~2018):カナダ
    Product Synopsis The Future of the Syrups & Spreads Market in Canada to 2018 is the result of Canadean’s extensive market research. The report presents detailed analysis on the Syrups & Spreads consumption trends in Canada, historic and forecast Syrups & Spreads consumption volumes and values at mar …
  • スティル及びスパークリング・ワイン市場展望(~2018):スペイン
    Summary - The Future of the Still and Sparkling Wine Market in Spain to 2018 is the result of Canadean's extensive market research covering the Still and Sparkling Wine market in Spain. - The report presents detailed data on the Still and Sparkling Wine consumption trends in Spain, historic and fore …
  • ハニカム紙の世界市場2016
    The Global Honeycomb Paper Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Honeycomb Paper industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. …
  • Knotted Carpet and Rug Market(結びカーペット及び敷物市場)s in the Top 5 American Countries to 2018 – Market Size, Trends, and Forecasts
    The industry report package Knotted Carpet and Rug Markets in the Top 5 American Countries to 2018 - Market Size, Trends, and Forecasts offers the most up-to-date perspective on the actual market situation, trends, and future outlook for knotted carpets and rugs in Americas. The package includes cou …
  • 仮想訓練の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    Virtual training is a simulated virtual environment which is created to assess the capabilities of trainees to select the right resource. The virtual training simulation is of two kinds, namely instructor-led training and non-instructor-supported training. Simulation, by definition is a process of i …
  • ウルグアイの肥料市場(~2019)
    The industry report Fertilizer Market in Uruguay to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for fertilizers in Uruguay. The research includes historic market data from 2008 to 2014 and forecasts until 20 …
  • 透明色マスターバッチの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Transparent Color Masterbatch Revenue, means the sales value of Transparent Color Masterbatch This report studies sales (consumption) of Transparent Color Masterbatch in Global market, especially in United States, China, Europe and Japan, focuses on top players …
  • Vygon SA:企業概要、戦略的SWOT分析
    Vygon SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • 世界及び中国の5-ブロモ吉草酸エチル市場2016
    The 'Global and Chinese Ethyl 5-bromovalerate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Ethyl 5-bromovalerate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ethyl 5- …
  • 世界の農用トラクタ市場2015
    The Global Farm Tractors Industry Report 2015 is a professional and in-depth study on the current state of the Farm Tractors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Farm Tractors market analy …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016305 )"高尿酸血症(Hyperuricemia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。